Clinical Trials Browser

Phase 2 × Advanced Solid Tumors × Erlotinib Hydrochloride × Clear all

NCT02057380 2024-11-20

A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial

Phase 2 Completed

Other solid neoplasm

Advanced Solid Tumors